Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Public ClinicalTrials.gov record NCT01579994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Study of Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
About 18 patients will take part in the phase 1 portion of the trial. In the beginning of the study, 3 patients will be treated with a low dose of ganetespib (STA-9090) and the standard dose of crizotinib. If this dose does not cause significant side effects, it will be increased as new patients take part in the study. The study will only be open at Memorial Sloan Kettering Cancer Center.
Study identification
- NCT ID
- NCT01579994
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 15, 2012
- Primary completion
- Dec 27, 2020
- Completion
- Dec 27, 2020
- Last update posted
- Dec 29, 2020
2012 – 2020
United States locations
- U.S. sites
- 5
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memoral Sloan Kettering Cancer Center | Basking Ridge | New Jersey | — | — |
| Memorial Sloan Kettering Cancer Center @ Suffolk | Commack | New York | 11725 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Memorial Sloan Kettering at Mercy Medical Center | Rockville Centre | New York | — | — |
| Memoral Sloan Kettering Cancer Center at Phelps | Sleepy Hollow | New York | 10591 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Advanced Lung Cancer trials
Other public records listing Advanced Lung Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT06228209: Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer Recruiting
- NCT06892548: A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer Recruiting
- NCT06625775: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors Recruiting
- NCT07227623: A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors Recruiting
- NCT06555588: Engage Psychosocial Intervention for Cancer Symptoms Recruiting
- NCT07391956: Tier Palliative Care For Patients With Advanced Heart Failure or Cancer Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01579994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 29, 2020 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01579994 live on ClinicalTrials.gov.